Your browser doesn't support javascript.
loading
Mtss1 is a critical epigenetically regulated tumor suppressor in CML.
Schemionek, M; Herrmann, O; Reher, M M; Chatain, N; Schubert, C; Costa, I G; Hänzelmann, S; Gusmao, E G; Kintsler, S; Braunschweig, T; Hamilton, A; Helgason, G V; Copland, M; Schwab, A; Müller-Tidow, C; Li, S; Holyoake, T L; Brümmendorf, T H; Koschmieder, S.
Affiliation
  • Schemionek M; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
  • Herrmann O; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
  • Reher MM; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
  • Chatain N; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
  • Schubert C; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
  • Costa IG; IZKF Research Group Bioinformatics, Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany.
  • Hänzelmann S; IZKF Research Group Bioinformatics, Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany.
  • Gusmao EG; IZKF Research Group Bioinformatics, Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany.
  • Kintsler S; Institute of Pathology, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
  • Braunschweig T; Institute of Pathology, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
  • Hamilton A; Haematopoietic Stem Cell Laboratory, London Research Institute, Cancer Research UK, London, UK.
  • Helgason GV; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Copland M; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Schwab A; Institute of Physiology II, University of Münster, Münster, Germany.
  • Müller-Tidow C; Department of Hematology and Oncology, University of Halle, Halle, Germany.
  • Li S; University of Massachusetts Medical School, Worcester, MA, USA.
  • Holyoake TL; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Brümmendorf TH; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
  • Koschmieder S; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
Leukemia ; 30(4): 823-32, 2016 Apr.
Article in En | MEDLINE | ID: mdl-26621336
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Cell Movement / Fusion Proteins, bcr-abl / Cell Proliferation / Microfilament Proteins / Neoplasm Proteins Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2016 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Cell Movement / Fusion Proteins, bcr-abl / Cell Proliferation / Microfilament Proteins / Neoplasm Proteins Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2016 Type: Article Affiliation country: Germany